Holds 2 active US DMFs for rilpivirine, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds 2 active US DMFs for rilpivirine, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for rilpivirine, filing since 2017. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF for rilpivirine, filing since 2013. Its 2025 FDA inspection closed as VAI.
Holds 4 active US DMFs for rilpivirine, filing since 2016. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
This page filters the worldwide Rilpivirine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free